个人科研网厅 | | 帮助
首都医科大学宣武医院知识库
高级检索
当前位置： 首页 > 详情页

Chinese expert consensus on the management of hypertension in adults with type 2 diabetes

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Pan, Xiaohui[1] * ; He, Hongbo[2,3] * ; Bao, Yuqian[4] ; Bi, Yan[5] ; Chen, Luyuan[6,7] ; Chen, Xiaoping[8] ; Fang, Hui[9] ; Feng, Wenhuan[5] ; Gao, Ling[10] ; Guo, Lixin[11,12,13] ; Guo, Yifang[14] ; Han, Yaling[15,16] ; Hua, Qi[17] ; Li, Nanfang[18] ; Li, Quanmin[19] ; Li, Yan[20,21] ; Li, Yong[22] ; Li, Xialian[23] ; Liu, Jing[24] ; Ma, Huijuan[25] ; Mu, Jianjun[26] ; Nong, Kailei[1] ; Shang, Huiqian[27] ; Shen, Yunfeng[28] ; Shi, Zhongwei[29] ; Sun, Fang[30] ; Sun, Ningling[24] ; Tao, Jun[31] ; Wang, Jiguang[21,32] ; Wang, Xinling[33] ; Wu, Jing[34] ; Xiao, Xinhua[35] ; Xie, Liangdi[36] ; Xu, Jing[37,38] ; Xu, Jing[37,38] ; Ye, Hongying[39] ; Yu, Dongni[11] ; Yuan, Hong[40] ; Zhang, Huijie[41] ; Zhang, Jian[42] ; Zhang, Lili[43] ; Zhang, Yuqing[44] ; Zhou, Jiaqiang[45] ; Zhou, Xinli[46] ; Zhu, Dalong[5] ; Zhu, Tiehong[46] ; Li, Sheyu[1] ; Zhu, Zhiming[2,3] ;
机构： [1]Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu, Peoples R China [2]Army Med Univ, Chongqing Inst Hypertens, Chongqing, Peoples R China [3]Chongqing Inst Hypertens, Chongqing, Peoples R China [4]Shanghai Jiao Tong Univ, Dept Otorhinolaryngol, Peoples Hosp 6, Sch Med, Shanghai, Peoples R China [5]Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Endocrinol, Nanjing, Peoples R China [6]Peoples Hosp Guangdong Prov, Dept Cardiol, Guangzhou, Peoples R China [7]Guangzhou Inst Cardiovasc Dis, Guangzhou, Peoples R China [8]Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu, Peoples R China [9]Hebei Med Univ, Tangshan City Workers Hosp, Dept Endocrinol, Tangshan 063000, Hebei, Peoples R China [10]Wuhan Univ, Dept Endocrinol, Renmin Hosp, Wuhan, Peoples R China [11]Beijing Hosp, Minist Hlth, Dept Endocrinol, Beijing, Peoples R China [12]China Natl Ctr Bioinformat, Beijing, Peoples R China [13]Chinese Acad Med Sci, Inst Geriatr, Beijing, Peoples R China [14]Hebei Gen Hosp, Dept Geriatr Cardiovasc Med, Shijiazhuang, Peoples R China [15]Gen Hosp Northern Theater Command, Dept Cardiol, Shenyang, Peoples R China [16]Shenyang Mil Command, Shenyang, Peoples R China [17]Capital Med Univ, Xuanwu Hosp, Dept Cardiol, Beijing, Peoples R China [18]Peoples Hosp Xinjiang Uygur Autonomous Reg, Ctr Hypertens, Urumqi, Peoples R China [19]PLA Rocket Force Characterist Med Ctr, Dept Endocrinol, Beijing, Peoples R China [20]Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai, Peoples R China [21]Shanghai Res Inst Hypertens, Shanghai, Peoples R China [22]Fudan Univ, Huashan Hosp, Dept Cardiol, Shanghai, Peoples R China [23]Zhengzhou Univ, Affiliated Hosp 1, Dept Endocrinol, Zhengzhou, Peoples R China [24]Peking Univ Peoples Hosp, Cardiovasc Med Dept, Beijing, Peoples R China [25]Hebei Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shijiazhuang, Hebei, Peoples R China [26]Xi An Jiao Tong Univ, Dept Reprod Med, Affiliated Hosp 1, Xian, Peoples R China [27]Zunyi Med Univ, Dept Cardiovasc Med, Affiliated Hosp, Zunyi, Peoples R China [28]Sun Yat Sen Univ, Affiliated Hosp 8, Dept Endocrinol & Metab, Shenzhen, Peoples R China [29]Army Med Univ, Daping Hosp, Army Special Med Ctr, Dept Hypertens & Endocrinol, Chongqing, Peoples R China [30]Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Peoples R China [31]Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hypertens, Shanghai, Peoples R China [32]Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Endocrinol, Urumqi, Peoples R China [33]Cent South Univ, Dept Endocrinol, Xiangya Hosp, Changsha, Peoples R China [34]Univ South China, Affiliated Hosp 1, Dept Endocrinol & Metab, Changsha, Peoples R China [35]Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China [36]Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Endocrinol, Xian, Peoples R China [37]Army Med Univ, Xinqiao Hosp, Dept Endocrinol, Chongqing, Peoples R China [38]Fudan Univ, Huashan Hosp, Dept Endocrinol, Shanghai, Peoples R China [39]Cent South Univ, Dept Gynecol, Xiangya Hosp 3, Changsha, Peoples R China [40]Southern Med Univ, Nanfang Hosp, Dept Endocrinol, Guangzhou, Peoples R China [41]Hubei Prov Hosp TCM, Dept Encephalopathy, Wuhan, Peoples R China [42]Chongqing Med Univ, Dept Cardiol, Affiliated Hosp 2, Chongqing, Peoples R China [43]Chinese Acad Med Sci, Dept Cardiovasc Surg, Fuwai Hosp, Beijing, Peoples R China [44]Zhejiang Univ, Sir Run Shaw Hosp, Sch Med, Dept Endocrinol & Metab, Hangzhou, Peoples R China [45]Shandong First Med Univ, Dept Endocrinol & Metab, Shandong Prov Hosp, Jinan, Peoples R China [46]Tianjin Med Univ, Dept Endocrinol & Metab, Gen Hosp, Tianjin, Peoples R China
出处：
DOI： 10.1111/jebm.12655
ISSN：

关键词： anti-hypertensive treatment blood pressure monitor hypertension screening for hypertension type 2 diabetes

摘要：
Both hypertension and type 2 diabetes are attributable to premature death, cardiovascular and kidney diseases with largely overlapping population. Followed the GRADE approach, this expert consensus aimed to reduce the cardiovascular and kidney death and disability due to hypertension and minimize the treatment burden in adults with type 2 diabetes. Through online survey and discussion, a multidisciplinary team comprehensively prioritized seven key guideline questions. Informed by the evidence synthesis and online discussion, the team developed 12 recommendations under the GRADE Evidence-to-decision (EtD) framework. The recommendations covered the screening of hypertension in adults diagnosed with type 2 diabetes but not hypertension and the monitoring, lifestyle interventions, and medications in those diagnosed with type 2 diabetes and hypertension.

基金：
The 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University [ZYYC24001]; National Natural Science Foundation of China [72342014, 81721001, 81920108010]
语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类 | 2 区 医学
小类 | 2 区 医学：内科
最新[2023]版：
大类 | 2 区 医学
小类 | 2 区 医学：内科
JCR分区：
出版当年[2022]版：
Q1 MEDICINE, GENERAL & INTERNAL
最新[2023]版：
Q1 MEDICINE, GENERAL & INTERNAL

影响因子： 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者：
第一作者机构： [1]Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu, Peoples R China
共同第一作者：
通讯作者：
通讯机构： [2]Army Med Univ, Chongqing Inst Hypertens, Chongqing, Peoples R China [3]Chongqing Inst Hypertens, Chongqing, Peoples R China
推荐引用方式(GB/T 7714)：
Pan Xiaohui,He Hongbo,Bao Yuqian,et al.Chinese expert consensus on the management of hypertension in adults with type 2 diabetes[J].JOURNAL OF EVIDENCE BASED MEDICINE.2024,doi:10.1111/jebm.12655.
APA：
Pan, Xiaohui,He, Hongbo,Bao, Yuqian,Bi, Yan,Chen, Luyuan...&Zhu, Zhiming.(2024).Chinese expert consensus on the management of hypertension in adults with type 2 diabetes.JOURNAL OF EVIDENCE BASED MEDICINE,,
MLA：
Pan, Xiaohui,et al."Chinese expert consensus on the management of hypertension in adults with type 2 diabetes".JOURNAL OF EVIDENCE BASED MEDICINE .(2024)

相关文献

[1]Validation of Type 2 Diabetes Risk Variants Identified by Genome-Wide Association Studies in Northern Han Chinese [2]妊娠期及哺乳期高血压疾病的治疗 [3]Birth weight and type 2 diabetes: A meta-analysis [4]厄贝沙坦与氨氯地平治疗2型糖尿病合并高血压的临床研究 [5]Changes in ideal cardiovascular health status and risk of new-onset type 2 diabetes: The Kailuan prospective study [6]DNase I aggravates islet -cell apoptosis in type 2 diabetes [7]National cardiovascular risk assessment in type 2 diabetes in China [8]Chiglitazar Added to Metformin for Type 2 Diabetes [9]Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients [10]2型糖尿病心血管病变高血压管理的研究进展

资源点击量：16409 今日访问量：0 总访问量：869 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持：重庆聚合科技有限公司 地址：北京市西城区长椿街45号宣武医院